The Globe and Mail reports in its Friday, May 3, edition that RBC Dominion Securities analyst Andrew Wong has reiterated his "outperform" recommendation for Cameco. The Globe's David Leeder writes in the Eye On Equities column that Mr. Wong gave his share target a $5 boost to $75. Analysts on average target the shares at $74.88. Mr. Wong says in a note: "We believe the company is well positioned to benefit from a renewed focus on nuclear energy and a tightening uranium market, especially as a Western-based producer in a market shift toward security of supply. Additionally, we think Cameco has the right mix of assets to meet the coming market needs: proven uranium production with upside, conversion capacity, potential long-term enrichment technology, and nuclear services through Westinghouse. We think Cameco shares remain reasonably valued with P/NAV at 1.3 times (using our $75/lb long-term price), compared to a historical range of 0.5–2.0 times, and EV/EBITDA on 2025 consensus at 15 times, which compares well as an industrials-type valuation given that 35 to 40 per cent of the business is Westinghouse and Fuel Services while uranium segment sales are based on a robust contract portfolio."